Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles
about
The great escape: viral strategies to counter BST-2/tetherinHIV-1 Vpu protein antagonizes innate restriction factor BST-2 via lipid-embedded helix-helix interactionsInterferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanismsThe restriction factors of human immunodeficiency virusHIV-1 Vpu targets cell surface markers CD4 and BST-2 through distinct mechanismsDifferential effects of human immunodeficiency virus type 1 Vpu on the stability of BST-2/tetherinBST-2/tetherin: a new component of the innate immune response to enveloped virusesAntiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteractionThe role of BST-2/Tetherin in host protection and disease manifestationHIV restriction in quiescent CD4⁺ T cellsTetherin restricts productive HIV-1 cell-to-cell transmissionThree-Dimensional Structural Characterization of HIV-1 Tethered to Human Cells.Native immunogold labeling of cell surface proteins and viral glycoproteins for cryo-electron microscopy and cryo-electron tomography applicationsStructural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformationsStructural insight into the mechanisms of enveloped virus tethering by tetherinStructural and Biophysical Analysis of BST-2/Tetherin Ectodomains Reveals an Evolutionary Conserved Design to Inhibit Virus ReleaseQuantitative multicolor super-resolution microscopy reveals tetherin HIV-1 interaction.Bone marrow stromal cell antigen 2 (BST-2) restricts mouse mammary tumor virus (MMTV) replication in vivoMechanism of HIV-1 virion entrapment by tetherinIntrinsic cellular defenses against human immunodeficiency virusesCounteraction of tetherin antiviral activity by two closely related SIVs differing by the presence of a Vpu geneTetherin Antagonism by HIV-1 Group M Nef Proteins.Modulation of HIV-1-host interaction: role of the Vpu accessory proteinAnimal models for HIV/AIDS researchUltra structural characterisation of tetherin - a protein capable of preventing viral release from the plasma membraneTetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicity.Antiviral activity of the interferon-induced cellular protein BST-2/tetherin.BST-2/tetherin-mediated restriction of chikungunya (CHIKV) VLP budding is counteracted by CHIKV non-structural protein 1 (nsP1)HIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cells.TIM-family proteins inhibit HIV-1 release.Serine-threonine ubiquitination mediates downregulation of BST-2/tetherin and relief of restricted virion release by HIV-1 Vpu.Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu proteinThe interferon-inducible host factor bone marrow stromal antigen 2/tetherin restricts virion release, but is it actually a viral restriction factor?Compensatory changes in the cytoplasmic tail of gp41 confer resistance to tetherin/BST-2 in a pathogenic nef-deleted SIVInsights into cellular factors that regulate HIV-1 replication in human cellsThe role of BST2/tetherin in feline retrovirus infectionVpu binds directly to tetherin and displaces it from nascent virions.Assembly and replication of HIV-1 in T cells with low levels of phosphatidylinositol-(4,5)-bisphosphate.Tetherin/BST-2 antagonism by Nef depends on a direct physical interaction between Nef and tetherin, and on clathrin-mediated endocytosis.Ex vivo gene therapy for HIV-1 treatment.
P2860
Q21090506-4BA608EC-7259-4C4F-8B1F-1C3D58B93975Q24296630-9527AE93-2A34-4F1A-92CA-77D9DF766450Q24302747-2F26A39B-DBCE-41A2-ADED-BAB9E853C172Q24605108-99405FBF-27CC-43E8-8B08-14879CB8D244Q24619066-396B0AE2-242E-4691-9BC6-8F6ACC532392Q24629504-3EC950B8-DB34-4B7D-A6ED-C296C0D53447Q24630382-72C983A1-223B-4D64-A491-AB5F7BEDC099Q24635271-6C6EFA55-60B7-4CB9-B6D5-23AF19D8A1F5Q26752737-FB564E10-F676-42AB-B393-74B935A8102FQ26995784-DDA8A9A4-6C5B-4DAF-B4A1-FAD4975F4931Q27314339-737F88AB-9FD6-4A37-8E12-7A7DD37CCFCFQ27321247-079EB0CA-CD82-4C0C-B1FA-EBAFA09439A0Q27335433-D656DA87-66EA-4475-9A01-933FD60A2676Q27664759-AE972BEC-565A-4653-8095-7679721EEBAFQ27664987-8F8828A0-05B0-4184-9F4A-58B16ECA40B8Q27665937-5892A686-1F76-4B7D-8DDD-BCE31F0A9555Q28478446-6711DB82-8A3D-48EB-8A51-F7AF6EA9E801Q28510187-FB76F648-F534-46C4-95CE-0AD9EFE9E845Q28534707-C51502BE-7A21-4EBF-947E-CAA0534913C4Q28659575-E9DC4B00-9046-4579-BFC4-DA8C8A159FECQ28730542-41856635-1399-4265-9B61-87E8B14B8070Q30393226-FFA7B326-B508-4706-BCB0-1D1797A989C4Q30397761-3E2B5912-C2C8-44C5-9D21-2A6488B79EEDQ30423656-E868A8DC-01B1-4067-AE0A-041574BD99F0Q31034125-BF33F15A-A184-43B9-A698-488A12C372A6Q33674461-ECA76001-60B9-462B-81D5-EB6CECE3F705Q33807551-9763386F-04F9-43F3-AB45-2EA3642F112AQ33861091-5D9F5F37-ECCF-4AFA-805D-D052AD052536Q33887674-E2D8AF5C-384D-408D-98C5-CCB2CA758B96Q34144143-0C763C07-2780-458B-9585-C3DE282F9A25Q34146128-D5B6B6CF-C87A-41A3-BA54-C151CFAB9919Q34416492-DCD80447-3522-4DCF-AA31-D6F953F8FEB0Q34492477-07FF4FDF-7036-4483-96D2-86D1256739C3Q34505213-93EBE873-3F16-4272-B269-3A557D508D0BQ34561070-6B549025-CFC2-46BD-9503-91F59BF814F0Q34664616-7F89FB3B-B18F-4E96-9FDE-2247AA55F159Q34697856-B5E261FE-F02C-437D-8C88-EC27741BE129Q34742397-9A7176F1-0D2F-44B8-948B-418A00CE2BBCQ34819697-1BFA15F2-599B-44D8-81E6-44B44A35E4D0Q34982851-E405212F-C1FE-4883-A95C-0DE11BA03A11
P2860
Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Direct restriction of virus re ...... ein BST-2 into HIV-1 particles
@ast
Direct restriction of virus re ...... ein BST-2 into HIV-1 particles
@en
Direct restriction of virus re ...... ein BST-2 into HIV-1 particles
@nl
type
label
Direct restriction of virus re ...... ein BST-2 into HIV-1 particles
@ast
Direct restriction of virus re ...... ein BST-2 into HIV-1 particles
@en
Direct restriction of virus re ...... ein BST-2 into HIV-1 particles
@nl
prefLabel
Direct restriction of virus re ...... ein BST-2 into HIV-1 particles
@ast
Direct restriction of virus re ...... ein BST-2 into HIV-1 particles
@en
Direct restriction of virus re ...... ein BST-2 into HIV-1 particles
@nl
P2093
P2860
P1433
P1476
Direct restriction of virus re ...... ein BST-2 into HIV-1 particles
@en
P2093
John Guatelli
Kathleen Fitzpatrick
Mark H Ellisman
Mark Skasko
Thomas J Deerinck
P2860
P304
P356
10.1371/JOURNAL.PPAT.1000701
P407
P577
2010-03-01T00:00:00Z